Peregrine Asset Advisers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $305K | Sell |
|
|||||
|
2024
Q4 | $362K | Sell |
|
|||||
|
2024
Q3 | $3.29M | Buy |
|
|||||
|
2024
Q2 | $316K | Hold |
|
|||||
|
2024
Q1 | $332K | Hold |
|
|||||
|
2023
Q4 | $303K | Sell |
|
|||||
|
2023
Q3 | $1.04M | Buy |
|
|||||
|
2023
Q2 | $719K | Hold |
|
|||||
|
2023
Q1 | $795K | Buy |
|
|||||
|
2022
Q4 | $649K | Sell |
|
|||||
|
2022
Q3 | $606K | Hold |
|
|||||
|
2022
Q2 | $649K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $6.64M | Buy |
|
|||||
|
2021
Q3 | $1.15M | Sell |
|
|||||
|
2021
Q2 | $1.21M | Buy |
|
|||||
|
2021
Q1 | $562K | Sell |
|
|||||
|
2020
Q4 | $657K | Buy |
|
|||||
|
2020
Q3 | $600K | Sell |
|
|||||
|
2020
Q2 | $535K | Sell |
|
|||||
|
2020
Q1 | $534K | Hold |
|
|||||
|
2019
Q4 | $612 | Hold |
|
|||||
|
2019
Q3 | $548K | Hold |
|
|||||
|
2019
Q2 | $553K | Sell |
|
|||||
|
2019
Q1 | $517K | Sell |
|
|||||
|
2018
Q4 | $427K | Sell |
|
|||||
|
2018
Q3 | $1.44M | Hold |
|
|||||
|
2018
Q2 | $1.22M | Hold |
|
|||||
|
2018
Q1 | $1.22M | Buy |
|
|||||
|
2017
Q4 | $741K | Buy |
|
|||||
|
2017
Q3 | $657K | Sell |
|
|||||
|
2017
Q2 | $709K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $206K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $757K | Sell |
|
|||||
|
2013
Q2 | $738K | Buy |
|